Patient experiences with a transitional, low-threshold clinic for the treatment of substance use disorder: A qualitative study of a bridge clinic

被引:62
|
作者
Snow, Rachel L. [1 ]
Simon, Rachel E. [2 ,3 ]
Jack, Helen E. [4 ,5 ]
Oller, Devin [6 ]
Kehoe, Laura [2 ,3 ]
Wakeman, Sarah E. [2 ,3 ]
机构
[1] Massachusetts Gen Hosp, Dept Psychiat, 55 Fruit St, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Div Gen Internal Med, 55 Fruit St, Boston, MA 02114 USA
[3] Harvard Med Sch, 25 Shattuck St, Boston, MA 02115 USA
[4] Univ Washington, Dept Med, 1959 NE Pacific St, Seattle, WA 98195 USA
[5] Kings Coll London, Inst Psychiat Psychol & Neurosci, 16 Crespigny Pk, London SE5 8AF, England
[6] Univ Kentucky, Coll Med, Div Gen Internal Med, 800 Rose St,MN 150, Lexington, KY 40506 USA
关键词
Substance use disorders; Low threshold; Transitional clinic; Bridge clinic; Harm reduction; Patient experience in treatment; Outpatient services; HEALTH-SERVICES; CARE; BUPRENORPHINE/NALOXONE; PERSPECTIVES; PROGRAM; PEOPLE;
D O I
10.1016/j.jsat.2019.09.003
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: A minority of patients with substance use disorder (SUD) receives treatment, indicating the need for innovation in care for individuals with SUD. Transitional and low threshold models of care for SUD are utilized to address this treatment gap, but there is limited evidence about their effectiveness or patient perspectives on these models. Methods: Patients participated in semi-structured interviews (N = 29) which explored their experience in a transitional, low threshold, Bridge clinic for the treatment of SUD. In order to reach a diverse patient population across age, gender, housing status, type of SUD, length of stay, and patient status in the clinic, researchers employed maximum variation sampling. Interviews were conducted until no new central concepts emerged. Codes were developed and assigned using an inductive as well as a mixed inductive-deductive approach. Results: Patients identified flexibility and accessibility of services, compassionate approach of providers and staff, use of peers in recovery, and the emphasis on harm reduction as positive features of the model. Patients struggled with transitioning out of the clinic. Conclusion: Patients reported positive experiences in a transitional, low threshold clinic for SUD, comparing it favorably to other programs. Patients maintained sobriety more consistently and increasing motivation to adhere to treatment. Patients almost universally appreciated the flexible and harm reduction-oriented model of treatment. Future quantitative research is needed to further examine the effects of low threshold programs on treatment outcomes, including ongoing substance use, treatment retention and overdose mortality, as compared to traditional treatment programs.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 45 条
  • [21] Patient Experiences Using a Self-Monitoring App in Eating Disorder Treatment: Qualitative Study
    Lindgreen, Pil
    Lomborg, Kirsten
    Clausen, Loa
    JMIR MHEALTH AND UHEALTH, 2018, 6 (06):
  • [22] Higher buprenorphine dose associated with increased treatment retention at low threshold buprenorphine clinic: A retrospective cohort study
    Selitsky, Lea
    Nordeck, Courtney
    Truong, Ashley
    Agus, Deborah
    Buresh, Megan E.
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2023, 147
  • [23] Former inpatients' narratives of substance use four years after substance use disorder treatment: A qualitative follow-up study
    Hystad, Jacob
    Wangensteen, Turid
    NORDIC STUDIES ON ALCOHOL AND DRUGS, 2022, 39 (02) : 190 - 202
  • [24] Sexually Transmitted and Blood-borne Infections Among Patients Presenting to a Low-barrier Substance Use Disorder Medication Clinic
    Harvey, Leah
    Taylor, Jessica L.
    Assoumou, Sabrina A.
    Kehoe, Jessica
    Schechter-Perkins, Elissa M.
    Bernstein, Edward
    Walley, Alexander Y.
    JOURNAL OF ADDICTION MEDICINE, 2021, 15 (06) : 461 - 467
  • [25] Why clinicians do not implement integrated treatment for comorbid substance use disorder and posttraumatic stress disorder: a qualitative study
    Gielen, Nele
    Krumeich, Anja
    Havermans, Remco C.
    Smeets, Feikje
    Jansen, Anita
    EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY, 2014, 5
  • [26] Patient centered medication treatment for opioid use disorder in rural Vermont: a qualitative study
    Hichborn, Emily G.
    Murray, Owen B.
    Murphy, Eilis I.
    Gallant, Tess E.
    Moore, Sarah K.
    Mcleman, Bethany M.
    Saroyan, John
    Folland, Anthony
    Mitchell, Megan
    Marsch, Lisa A.
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2025, 20 (01):
  • [27] Implementing a peer-supported, integrated strategy for substance use disorder care in an outpatient infectious disease clinic is associated with improved patient outcomes
    Falade-Nwulia, Oluwaseun
    Agee, Tracy
    Kelly, Sharon M.
    Park, Ju Nyeong
    Schwartz, Sheree
    Hsu, Jeffrey
    Schweizer, Nicholas
    Jones, Joyce
    Keruly, Jeanne
    Shah, Nishant
    Lesko, Catherine R.
    Lucas, Gregory M.
    Sulkowski, Mark
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2023, 121
  • [28] State-level actions targeting unethical substance use disorder treatment practices: A qualitative study
    Davoust, Melissa
    Nguyen, Phiyen
    Adelberg, Michael
    Frakt, Austin
    Garrido, Melissa M.
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2025, 170
  • [29] Factors associated with patient-reported experiences and outcomes of substance use disorder treatment in Cape Town, South Africa
    Myers, Bronwyn
    Koch, J. Randy
    Johnson, Kim
    Harker, Nadine
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2022, 17 (01)
  • [30] A qualitative study of reasons to use substances and substance use treatment experiences among transgender and gender diverse adults in Rhode Island
    Kelly, Patrick J. A.
    Myers-Matthews, Paige
    Collins, Alexandra B.
    Wolfe, Hill L.
    Miller-Jacobs, Cameron
    Davis, Madison
    Adrian, Haley
    Briody, Victoria
    Fernandez, Yohansa
    Operario, Don
    Hughto, Jaclyn M. W.
    SSM-QUALITATIVE RESEARCH IN HEALTH, 2024, 5